|
NatrecorDrug - Natrecor The trade name of the product as shown on the labeling.
Dosage -
FOR SOLUTION; INTRAVENOUS
Active Ingredient(s) -
Nesiritide Recombinant
Strength -
1.5MG/VIAL
Applicant -
SCIOS
New Drug Application (NDA) Number -
020920
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 10, 2001
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Scios Inc
Natrecor
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical
Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Ointment; Topical Nevanac 0.1% Suspension/drops; Ophthalmic Natrecor 1.5mg/vial For Solution; Intravenous Neo-delta-cortef Eq 3.5mg Base/ml;0.25% Suspension/drops; Ophthalmic Neo-hydeltrasol Eq 3.5mg Base/gm;eq 0.25% Phosphate Ointment; Ophthalmic Mytrex A Eq 3.5mg Base/gm;0.1% Cream; Topical Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Mytrex A Eq 3.5mg Base/gm;0.1% Ointment; Topical NewDrugInformation |